Reviews Atomoxetine HCl

Strattera Drug Description
STRATTERA®
(atomoxetine hydrochloride) Capsules for Oral Use

WARNING
SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS
STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term
studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder
(ADHD). Anyone considering the use of STRATTERA in a child or adolescent must
balance this risk with the clinical need. Co-morbidities occurring with ADHD
may be associated with an increase in the risk of suicidal ideation and/or behavior.
Patients who are started on therapy should be monitored closely for suicidality
(suicidal thinking and behavior), clinical worsening, or unusual changes in
behavior. Families and caregivers should be advised of the need for close observation
and communication with the prescriber. STRATTERA is approved for ADHD in pediatric
and adult patients. STRATTERA is not approved for major depressive disorder.

Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials
of STRATTERA in children and adolescents (a total of 12 trials involving over
2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed
a greater risk of suicidal ideation early during treatment in those receiving
STRATTERA compared to placebo. The average risk of suicidal ideation in patients
receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated
patients (851 patients). No suicides occurred in these trials [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of atomoxetine (Strattera)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking atomoxetine and call your doctor at once if you have a serious side effect such as:

chest pain, shortness of breath, fast or uneven heartbeats;
feeling light-headed or fainting;
unusual thoughts or behavior, aggression, hallucinations (seeing things that are not there);
nausea, stomach...
Read All Potential Side Effects for Strattera »




STRATTERA® (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor.
Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical
designation is (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride.
The molecular formula is C17H21NO•HCl, which corresponds
to a molecular weight of 291.82. The chemical structure is:








Atomoxetine HCl is a white to practically white solid, which has a solubility
of 27.8 mg/mL in water.
STRATTERA capsules are intended for oral administration only.
Each capsule contains atomoxetine HCl equivalent to 10, 18, 25, 40, 60, 80,
or 100 mg of atomoxetine. The capsules also contain pregelatinized starch and
dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate, and
other inactive ingredients. The capsule shells also contain one or more of the
following:
FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide, red iron
oxide. The capsules are imprinted with edible black ink.
Last reviewed on RxList: 8/20/2010




Strattera Drug Description
STRATTERA®
(atomoxetine hydrochloride) Capsules for Oral Use

WARNING
SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS
STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term
studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder
(ADHD). Anyone considering the use of STRATTERA in a child or adolescent must
balance this risk with the clinical need. Co-morbidities occurring with ADHD
may be associated with an increase in the risk of suicidal ideation and/or behavior.
Patients who are started on therapy should be monitored closely for suicidality
(suicidal thinking and behavior), clinical worsening, or unusual changes in
behavior. Families and caregivers should be advised of the need for close observation
and communication with the prescriber. STRATTERA is approved for ADHD in pediatric
and adult patients. STRATTERA is not approved for major depressive disorder.

Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials
of STRATTERA in children and adolescents (a total of 12 trials involving over
2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed
a greater risk of suicidal ideation early during treatment in those receiving
STRATTERA compared to placebo. The average risk of suicidal ideation in patients
receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated
patients (851 patients). No suicides occurred in these trials [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of atomoxetine (Strattera)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking atomoxetine and call your doctor at once if you have a serious side effect such as:

chest pain, shortness of breath, fast or uneven heartbeats;
feeling light-headed or fainting;
unusual thoughts or behavior, aggression, hallucinations (seeing things that are not there);
nausea, stomach...
Read All Potential Side Effects for Strattera »




STRATTERA® (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor.
Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical
designation is (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride.
The molecular formula is C17H21NO•HCl, which corresponds
to a molecular weight of 291.82. The chemical structure is:








Atomoxetine HCl is a white to practically white solid, which has a solubility
of 27.8 mg/mL in water.
STRATTERA capsules are intended for oral administration only.
Each capsule contains atomoxetine HCl equivalent to 10, 18, 25, 40, 60, 80,
or 100 mg of atomoxetine. The capsules also contain pregelatinized starch and
dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate, and
other inactive ingredients. The capsule shells also contain one or more of the
following:
FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide, red iron
oxide. The capsules are imprinted with edible black ink.
Last reviewed on RxList: 8/20/2010




Strattera Drug Description
STRATTERA®
(atomoxetine hydrochloride) Capsules for Oral Use

WARNING
SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS
STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term
studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder
(ADHD). Anyone considering the use of STRATTERA in a child or adolescent must
balance this risk with the clinical need. Co-morbidities occurring with ADHD
may be associated with an increase in the risk of suicidal ideation and/or behavior.
Patients who are started on therapy should be monitored closely for suicidality
(suicidal thinking and behavior), clinical worsening, or unusual changes in
behavior. Families and caregivers should be advised of the need for close observation
and communication with the prescriber. STRATTERA is approved for ADHD in pediatric
and adult patients. STRATTERA is not approved for major depressive disorder.

Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials
of STRATTERA in children and adolescents (a total of 12 trials involving over
2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed
a greater risk of suicidal ideation early during treatment in those receiving
STRATTERA compared to placebo. The average risk of suicidal ideation in patients
receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated
patients (851 patients). No suicides occurred in these trials [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of atomoxetine (Strattera)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking atomoxetine and call your doctor at once if you have a serious side effect such as:

chest pain, shortness of breath, fast or uneven heartbeats;
feeling light-headed or fainting;
unusual thoughts or behavior, aggression, hallucinations (seeing things that are not there);
nausea, stomach...
Read All Potential Side Effects for Strattera »




STRATTERA® (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor.
Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical
designation is (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride.
The molecular formula is C17H21NO•HCl, which corresponds
to a molecular weight of 291.82. The chemical structure is:








Atomoxetine HCl is a white to practically white solid, which has a solubility
of 27.8 mg/mL in water.
STRATTERA capsules are intended for oral administration only.
Each capsule contains atomoxetine HCl equivalent to 10, 18, 25, 40, 60, 80,
or 100 mg of atomoxetine. The capsules also contain pregelatinized starch and
dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate, and
other inactive ingredients. The capsule shells also contain one or more of the
following:
FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide, red iron
oxide. The capsules are imprinted with edible black ink.
Last reviewed on RxList: 8/20/2010




Strattera Drug Description
STRATTERA®
(atomoxetine hydrochloride) Capsules for Oral Use

WARNING
SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS
STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term
studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder
(ADHD). Anyone considering the use of STRATTERA in a child or adolescent must
balance this risk with the clinical need. Co-morbidities occurring with ADHD
may be associated with an increase in the risk of suicidal ideation and/or behavior.
Patients who are started on therapy should be monitored closely for suicidality
(suicidal thinking and behavior), clinical worsening, or unusual changes in
behavior. Families and caregivers should be advised of the need for close observation
and communication with the prescriber. STRATTERA is approved for ADHD in pediatric
and adult patients. STRATTERA is not approved for major depressive disorder.

Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials
of STRATTERA in children and adolescents (a total of 12 trials involving over
2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed
a greater risk of suicidal ideation early during treatment in those receiving
STRATTERA compared to placebo. The average risk of suicidal ideation in patients
receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated
patients (851 patients). No suicides occurred in these trials [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of atomoxetine (Strattera)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking atomoxetine and call your doctor at once if you have a serious side effect such as:

chest pain, shortness of breath, fast or uneven heartbeats;
feeling light-headed or fainting;
unusual thoughts or behavior, aggression, hallucinations (seeing things that are not there);
nausea, stomach...
Read All Potential Side Effects for Strattera »




STRATTERA® (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor.
Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical
designation is (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride.
The molecular formula is C17H21NO•HCl, which corresponds
to a molecular weight of 291.82. The chemical structure is:








Atomoxetine HCl is a white to practically white solid, which has a solubility
of 27.8 mg/mL in water.
STRATTERA capsules are intended for oral administration only.
Each capsule contains atomoxetine HCl equivalent to 10, 18, 25, 40, 60, 80,
or 100 mg of atomoxetine. The capsules also contain pregelatinized starch and
dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate, and
other inactive ingredients. The capsule shells also contain one or more of the
following:
FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide, red iron
oxide. The capsules are imprinted with edible black ink.
Last reviewed on RxList: 8/20/2010




Strattera Drug Description
STRATTERA®
(atomoxetine hydrochloride) Capsules for Oral Use

WARNING
SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS
STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term
studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder
(ADHD). Anyone considering the use of STRATTERA in a child or adolescent must
balance this risk with the clinical need. Co-morbidities occurring with ADHD
may be associated with an increase in the risk of suicidal ideation and/or behavior.
Patients who are started on therapy should be monitored closely for suicidality
(suicidal thinking and behavior), clinical worsening, or unusual changes in
behavior. Families and caregivers should be advised of the need for close observation
and communication with the prescriber. STRATTERA is approved for ADHD in pediatric
and adult patients. STRATTERA is not approved for major depressive disorder.

Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials
of STRATTERA in children and adolescents (a total of 12 trials involving over
2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed
a greater risk of suicidal ideation early during treatment in those receiving
STRATTERA compared to placebo. The average risk of suicidal ideation in patients
receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated
patients (851 patients). No suicides occurred in these trials [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of atomoxetine (Strattera)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking atomoxetine and call your doctor at once if you have a serious side effect such as:

chest pain, shortness of breath, fast or uneven heartbeats;
feeling light-headed or fainting;
unusual thoughts or behavior, aggression, hallucinations (seeing things that are not there);
nausea, stomach...
Read All Potential Side Effects for Strattera »




STRATTERA® (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor.
Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical
designation is (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride.
The molecular formula is C17H21NO•HCl, which corresponds
to a molecular weight of 291.82. The chemical structure is:








Atomoxetine HCl is a white to practically white solid, which has a solubility
of 27.8 mg/mL in water.
STRATTERA capsules are intended for oral administration only.
Each capsule contains atomoxetine HCl equivalent to 10, 18, 25, 40, 60, 80,
or 100 mg of atomoxetine. The capsules also contain pregelatinized starch and
dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate, and
other inactive ingredients. The capsule shells also contain one or more of the
following:
FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide, red iron
oxide. The capsules are imprinted with edible black ink.
Last reviewed on RxList: 8/20/2010

FDA Directs ADHD Drug Manufacturers To Notify Patients About Adverse Reactions
  by Mark
The U.S. Food and Drug Administration (FDA) today directed the manufacturers of all drug products approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) to develop Patient […]

a medicated wonder
  by bipolarlife
I am on what I believe to be the best drug combination that I have ever been on to treat my symptoms. Not only do I feel relatively […]

Study Suggests Strattera(R) Improved ADHD Symptoms In Patients With Comorbid Alcohol Abuse
  by Mark
Data from a recent clinical study showed Strattera(R) (atomoxetine HCl) improved symptoms of Attention- Deficit/Hyperactivity Disorder (ADHD) in patients with comorbid alcohol abuse disorder, suggesting ADHD can be […]

Procrastination
  by almarose
Discovered Online: eBay Store Success Tips TIP # 1 (from Tonya's Dynamic Designs) [caption id="attachment_249" align="alignright" width="140" caption="SOLD for $1"][/caption] Have a Professional eBay Store or Website Designed with Search Engine […]

Obama and Tonya #3
  by almarose
Valuable eBay Selling Tip   [caption id="attachment_334" align="alignright" width="212" caption="Hardcover, 3 Jane Austen novels, SOLD for $2.99 plus $4.30 shipping"][/caption] From Tonya’s Dynamic Designs, specializing in eBay stores and more....   TIP # 3: […]

Med Experience
  by bipolarlife
– Copyright © 2004 - 2009 bipolarlife.wordpress.com. This Feed is for personal non-commercial use only. If you are not reading this material in your news aggregator, the site […]

STRATTERA® (atomoxetine hydrochloride) CAPSULES for Oral Use
  by kanlayanee
STRATTERA 18 MG CAPSULE STRATTERA® (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor. Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. Adult Min/Max Dose: 40.0mg/100.0mg Common […]

Antidepressants, shooting rampages, suicide and senseless violence
  by neighborhoodwatcher
Thank you for clicking this link to find out more. Ever since the new class of antidepressants hit the market in the mid-80s, we have stood by and watched […]

Such a fighting is rarely vouch
  by ahmswnmoavx
It looked utterly undistinguished. They were at the entrance to the Grove. Before Ben had time for more than a grateful look, a tumbled head appeared […]

The large majority were suppo
  by miieqybahpk
The thing was accomplished, and so easily. Penn he saw his folk drowned all n a heap fore he rightly knew what was comin. As he spoke one […]

Atomoxetine may be quantitated in plasma, serum or whole blood in order to distinguish ... All disclosed Lilly trials; MSDS for Atomoxetine HCl; Strattera Related Published Studies Atomoxetine - Wikipedia, the free encyclopedia

Find patient medical information for Atomoxetine Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Atomoxetine Oral : Uses, Side Effects, Interactions, Pictures ...

Learn about the prescription medication Strattera (Atomoxetine HCl), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Strattera (Atomoxetine HCl) Drug Information: Uses, Side Effects ...

Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. The chemical designation is (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride. Atomoxetine, Strattera Pharmacology - HealthyPlace.com - HealthyPlace

Atomoxetine Hcl . CAS: 82248-59-7. Appearance: white crystal powder . Chemical Name: (R)-N-methyl-gamma-(2-methylphenoxy)-benzenepropanamine Atomoxetine--R&S PharmChem Co.,Ltd.

Drug Description DESCRIPTION. STRATTERA (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor. Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction. Strattera Drug Description - atomoxetine HCl - HealthScout

Strattera ® (atomoxetine HCl) is indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Atomoxetine (Strattera) from Eli Lilly

Buy Strattera (Atomoxetine Hcl) from our Canadian Online Pharmacy by calling 1-877-888-3562. Fully licensed, fast delivery, free doctor consultation provided. Buy Strattera (Atomoxetine Hcl) Online Now

Atomoxetine HCl is a white to practically white solid, which has a solubility of 27.8 mg/mL in water. What is ADHD? ADHD has 3 main types of symptoms: inattention, hyperactivity ... Atomoxetine::CHEM-ONLINE.org::

Drug information and side-effects for Strattera (atomoxetine HCl) Strattera (atomoxetine HCl) - Drug information from MediLexicon